Discovery of antiglioma activity of biaryl 1,2,3,4-tetrahydroisoquinoline derivatives and conformationally flexible analogues.
MichaelL Mohler, Gyong-Suk Kang, Seoung-Soo Hong, Renukadevi Patil, OlegV Kirichenko, Wei Li, IgorM Rakov, EldonE Geisert, DuaneD Miller
文献索引:J. Med. Chem. 49 , 5845-8, (2006)
全文:HTML全文
摘要
Cultured rat astrocytes and C6 rat glioma were used as a differential screen for a variety of 1,2,3,4-tetrahydroisoquinoline (THI) derivatives. Compound 1 [1-(biphenyl-4-ylmethyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol hydrochloride] selectively blocked the growth of C6 glioma leaving normal astrocytes relatively unaffected. The potential for clinical utility of 1 was further substantiated in human gliomas and other tumor cell lines. Preliminary SAR of this activity was characterized by synthesis and testing of several THI and conformationally flexible variants.
相关化合物
相关文献:
2014-09-30
[Oncotarget 5(18) , 8107-22, (2014)]
2014-10-15
[Eur. J. Pharm. Sci. 63 , 14-21, (2014)]
2015-01-07
[World J. Gastroenterol. 21(1) , 164-76, (2015)]
[Iran. J. Pharm. Res. 14(2) , 395-405, (2015)]
2015-08-01
[Cancer Sci. 106 , 1000-7, (2015)]